InMed Pharmaceuticals Inc.·4

Mar 9, 3:45 PM ET

HSU ERIC C 4

4 · InMed Pharmaceuticals Inc. · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-08
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2023-03-085458,333 total
    Exercise: $927.64From: 2018-03-08Exp: 2023-03-08Common shares (545 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00

Documents

1 file
  • 4
    ownership.xmlPrimary